Three-year follow-up of hematocrit levels in trans persons on gender affirming hormonal treatment: results from the European Network for the Investigation of Gender Incongruence (ENIGI)

被引：0
|
作者：
Defreyne, J. [1 ]
Vantomme, B. [1 ]
Van Caenegem, E. [1 ]
Wierckx, K. [1 ]
T'Sjoen, G. [2 ,3 ]
机构：
[1] Ghent Univ Hosp, Dept Endocrinol, Pintelaan 185, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Dept Endocrinol, Pintelaan 185, B-9000 Ghent, Belgium
[3] Ghent Univ Hosp, Ctr Sexol & Gender, Pintelaan 185, B-9000 Ghent, Belgium
来源：
ACTA CLINICA BELGICA | 2017年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [41] Three-year follow-up of aortic arch endovascular stent grafting with the Nexus device: results from a prospective multicentre study
    D'Onofrio, Augusto
    Lachat, Mario
    Mangialardi, Nicola
    Antonello, Michele
    Schelzig, Hubert
    Chaykovska, Lyubov
    Hill, Andrew
    Holden, Andrew
    Lindsay, Thomas
    Ten Tan, Kong
    Orrico, Matteo
    Ronchey, Sonia
    Greener, Gabby Elbaz
    Hayes, Paul
    Lorenzoni, Giulia
    Gerosa, Gino
    Planer, David
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 63 (01)
  • [42] Profile of adverse drug reactions reported via the Continuum plus platform: Results from three-year regional follow-up
    Henry, Juliette
    Fresse, Audrey
    Beurrier, Mathilde
    Antoine, Marie-Lauren
    Gillet, Pierre
    THERAPIE, 2024, 79 (06): : 692 - 698
  • [43] Letter to the Editor on "Desired decision-making role and treatment satisfaction among trans people during medical transition: results from the ENIGI follow-up study"
    Ashley, Florence
    Allen, Luke
    Gronsbell, Jessica
    JOURNAL OF SEXUAL MEDICINE, 2023, 20 (10): : 1258 - 1259
  • [44] Is coronary artery surgery still the treatment of choice in patients with diabetes and (BARI type) multivessel disease? Three-year follow-up results
    Kapur, A
    Bartolini, D
    Mostafavi, E
    Morgan, K
    Rickard, MC
    Hall, RJ
    Beatt, KJ
    EUROPEAN HEART JOURNAL, 2004, 25 : 424 - 424
  • [45] Gender differences in first-episode psychosis at 5-year follow-up - two different courses of disease? Results from the OPUS study at 5-year follow-up
    Thorup, A.
    Albert, N.
    Bertelsen, M.
    Petersen, L.
    Jeppesen, P.
    Le Quack, P.
    Krarup, G.
    Jorgensen, P.
    Nordentoft, M.
    EUROPEAN PSYCHIATRY, 2014, 29 (01) : 44 - 51
  • [46] Clinical, demographic characteristics, and treatment protocols of optic neuropathies: Three-year follow-up experiences from a tertiary hospital in Turkey
    Kandeger, Burcu Taskiran
    Tok, Ozlem
    Tok, Levent
    CURRENT JOURNAL OF NEUROLOGY, 2022, 21 (03): : 170 - 177
  • [47] Identifying methamphetamine users at risk for major depressive disorder: Findings from the methamphetamine treatment project at three-year follow-up
    Glasner-Edwards, Suzette
    Mooney, Larissa J.
    Marinelli-Casey, Patricia
    Hillhouse, Maureen
    Ang, Alfonso
    Rawson, Richard
    AMERICAN JOURNAL ON ADDICTIONS, 2008, 17 (02): : 99 - 102
  • [48] Three-Year Follow-up After Antiviral Treatment in New-Onset Type 1 Diabetes: Results From the Diabetes Virus Detection and Intervention Trial
    Mynarek, Ida M.
    Krogvold, Lars
    Mork, Freja B.
    Lawaetz, Trine W. H.
    Roald, Trine
    Fagerland, Morten W.
    Lindblom, Nina
    Westman, Jacob
    Barker, Peter
    Hyoty, Heikki
    Ludvigsson, Johnny
    Hanssen, Kristian F.
    Johannesen, Jesper
    Dahl-Jorgensen, Knut
    DIABETES CARE, 2025, 48 (03)
  • [49] A three-year follow-up of major depression, dysthymia, minor depression and subsyndromal depression: Results from a population-based study
    Forsell, Yvonne
    DEPRESSION AND ANXIETY, 2007, 24 (01) : 62 - 65
  • [50] Three-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis: Results from a randomized clinical trial
    Waksman, R
    Ajani, AE
    Kim, HS
    Pinnow, E
    Satler, LF
    Kent, KM
    Pichard, AD
    Bui, AB
    White, LR
    Lindsay, J
    CIRCULATION, 2001, 104 (17) : 348 - 349
12345